These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31317818)

  • 1. Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity.
    Camara-Lemarroy CR; Silva C; Greenfield J; Liu WQ; Metz LM; Yong VW
    Mult Scler; 2020 Oct; 26(11):1340-1350. PubMed ID: 31317818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-γ, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: Relevance for neuro-inflammatory diseases.
    Rahman MT; Ghosh C; Hossain M; Linfield D; Rezaee F; Janigro D; Marchi N; van Boxel-Dezaire AHH
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):274-279. PubMed ID: 30449598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis.
    Ciccia F; Guggino G; Rizzo A; Alessandro R; Luchetti MM; Milling S; Saieva L; Cypers H; Stampone T; Di Benedetto P; Gabrielli A; Fasano A; Elewaut D; Triolo G
    Ann Rheum Dis; 2017 Jun; 76(6):1123-1132. PubMed ID: 28069576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model.
    Ling X; Linglong P; Weixia D; Hong W
    PLoS One; 2016; 11(8):e0161635. PubMed ID: 27551722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis.
    Pellizoni FP; Leite AZ; Rodrigues NC; Ubaiz MJ; Gonzaga MI; Takaoka NNC; Mariano VS; Omori WP; Pinheiro DG; Matheucci Junior E; Gomes E; de Oliveira GLV
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy.
    Olsson A; Gustavsen S; Langkilde AR; Hansen TH; Sellebjerg F; Bach Søndergaard H; Oturai AB
    Mult Scler Relat Disord; 2021 Sep; 54():103136. PubMed ID: 34247104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Zonulin-transgenic mouse displays behavioral alterations ameliorated via depletion of the gut microbiota.
    Miranda-Ribera A; Serena G; Liu J; Fasano A; Kingsbury MA; Fiorentino MR
    Tissue Barriers; 2022 Jul; 10(3):2000299. PubMed ID: 34775911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves' Disease.
    Zheng D; Liao H; Chen S; Liu X; Mao C; Zhang C; Meng M; Wang Z; Wang Y; Jiang Q; Xue Y; Zhou L; Chen Y
    Front Endocrinol (Lausanne); 2021; 12():796212. PubMed ID: 34975767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of inflammation and epithelial barrier function in multiple sclerosis.
    Olsson A; Gustavsen S; Hasselbalch IC; Langkilde AR; Sellebjerg F; Oturai AB; Søndergaard HB
    Mult Scler Relat Disord; 2020 Nov; 46():102520. PubMed ID: 32980645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
    Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
    J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakdown of the gut barrier in patients with multiple organ dysfunction syndrome is attenuated by continuous blood purification: effects on tight junction structural proteins.
    Zhang JB; Du XG; Zhang H; Li ML; Xiao G; Wu J; Gan H
    Int J Artif Organs; 2010 Jan; 33(1):5-14. PubMed ID: 20127656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.
    Saresella M; Marventano I; Barone M; La Rosa F; Piancone F; Mendozzi L; d'Arma A; Rossi V; Pugnetti L; Roda G; Casagni E; Cas MD; Paroni R; Brigidi P; Turroni S; Clerici M
    Front Immunol; 2020; 11():1390. PubMed ID: 32733460
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
    Singh P; Silvester J; Chen X; Xu H; Sawhney V; Rangan V; Iturrino J; Nee J; Duerksen DR; Lembo A
    United European Gastroenterol J; 2019 Jun; 7(5):709-715. PubMed ID: 31210949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.
    Drago S; El Asmar R; Di Pierro M; Grazia Clemente M; Tripathi A; Sapone A; Thakar M; Iacono G; Carroccio A; D'Agate C; Not T; Zampini L; Catassi C; Fasano A
    Scand J Gastroenterol; 2006 Apr; 41(4):408-19. PubMed ID: 16635908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of Indirect Biomarkers of Intestinal Permeability in the Stools of Newborns and Infants with Perinatal Risk Factors for Intestinal Colonization Disorders and Infant Feeding Patterns.
    Sochaczewska D; Ziętek M; Dołęgowska B; Kordek A; Szczuko M
    Nutrients; 2022 May; 14(11):. PubMed ID: 35684026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonulin as a Potential Therapeutic Target in Microbiota-Gut-Brain Axis Disorders: Encouraging Results and Emerging Questions.
    Veres-Székely A; Szász C; Pap D; Szebeni B; Bokrossy P; Vannay Á
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis.
    Tajik N; Frech M; Schulz O; Schälter F; Lucas S; Azizov V; Dürholz K; Steffen F; Omata Y; Rings A; Bertog M; Rizzo A; Iljazovic A; Basic M; Kleyer A; Culemann S; Krönke G; Luo Y; Überla K; Gaipl US; Frey B; Strowig T; Sarter K; Bischoff SC; Wirtz S; Cañete JD; Ciccia F; Schett G; Zaiss MM
    Nat Commun; 2020 Apr; 11(1):1995. PubMed ID: 32332732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles.
    Miranda-Ribera A; Ennamorati M; Serena G; Cetinbas M; Lan J; Sadreyev RI; Jain N; Fasano A; Fiorentino M
    Front Immunol; 2019; 10():2233. PubMed ID: 31608059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluctuation of zonulin levels in blood
    Vojdani A; Vojdani E; Kharrazian D
    World J Gastroenterol; 2017 Aug; 23(31):5669-5679. PubMed ID: 28883692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the Significance of Zonulin in the Pathogenesis of Chronic Inflammatory Disorders: Emphasis on Intestinal Barrier Function and Tight Junction Regulation.
    Mohammadi-Kordkhayli M; Mousavi MJ; Camara-Lemarroy CR; Noorbakhsh F; Saboor-Yaraghi AA
    Curr Med Chem; 2024 Sep; ():. PubMed ID: 39252622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.